Annual report pursuant to Section 13 and 15(d)

Prepaid Expenses and Other Current Assets

v3.20.4
Prepaid Expenses and Other Current Assets
12 Months Ended
Dec. 31, 2020
Prepaid Expense And Other Assets Current [Abstract]  
Prepaid Expenses and Other Current Assets

(4)

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:

 

 

December 31, 2020

 

 

December 31, 2019

 

Refundable FDA filing fee (1)

 

$

2,876

 

 

 

-

 

Short-term deposits

 

 

2,360

 

 

 

1,139

 

Research and development tax credit receivable

 

 

801

 

 

 

1,036

 

Prepaid research and development expenses

 

 

157

 

 

 

1,679

 

Prepaid insurance

 

 

415

 

 

 

569

 

Value added tax receivable

 

 

64

 

 

 

68

 

Other prepaid assets

 

 

231

 

 

 

57

 

Deferred financing expenses

 

 

 

 

 

2,339

 

Total

 

$

6,904

 

 

$

6,887

 

(1) FDA filing fee refund of $2,876 was received in January 2021